Subbu Nambi
Stock Analyst at Guggenheim
(4.84)
# 402
Out of 4,596 analysts
176
Total ratings
65.9%
Success rate
29.5%
Average return
Main Sectors:
Stocks Rated by Subbu Nambi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TEM Tempus AI | Reiterated: Buy | $65 | $45.91 | +41.58% | 11 | Aug 3, 2026 | |
| VCYT Veracyte | Reiterated: Buy | $65 | $46.37 | +40.18% | 11 | Jul 31, 2026 | |
| GH Guardant Health | Reiterated: Buy | $190 | $162.10 | +17.22% | 17 | Jul 31, 2026 | |
| ILMN Illumina | Reiterated: Buy | $200 → $226 | $205.18 | +10.15% | 13 | Jul 30, 2026 | |
| NEOG Neogen | Reiterated: Buy | $12 | $12.18 | -1.48% | 8 | Jul 30, 2026 | |
| ADPT Adaptive Biotechnologies | Reiterated: Buy | $22 → $25 | $23.23 | +7.62% | 5 | Jul 29, 2026 | |
| NAUT Nautilus Biotechnology | Reiterated: Buy | $4 | $0.977 | +309.42% | 9 | Jul 28, 2026 | |
| DHR Danaher | Reiterated: Buy | $235 → $200 | $196.68 | +1.69% | 8 | Jul 21, 2026 | |
| BRKR Bruker | Maintained: Buy | $50 → $70 | $64.03 | +9.33% | 9 | Jun 29, 2026 | |
| NTRA Natera | Maintained: Buy | $270 → $290 | $267.34 | +8.48% | 7 | Jun 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $60 → $107 | $97.50 | +9.74% | 9 | Jun 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $70 → $74 | $66.43 | +11.40% | 8 | Jun 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $120 → $125 | $137.01 | -8.77% | 6 | Jun 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $75 | $71.00 | +5.63% | 11 | May 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $440 | $376.74 | +16.79% | 5 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $6.58 | - | 3 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $13 | $13.01 | -0.08% | 5 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $47 | $29.53 | +59.19% | 5 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $5.70 | +22.81% | 4 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 → $12 | $15.15 | -20.79% | 4 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $144.88 | - | 6 | Feb 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $1.45 | - | 1 | Feb 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $15.89 | - | 2 | Oct 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $115.27 | - | 2 | Oct 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €263.00 | €228.20 | +15.25% | 2 | Oct 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $32 | $16.48 | n/a | 1 | Jul 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $3.04 | n/a | 2 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $47.36 | n/a | 2 | Feb 23, 2025 |
Tempus AI
Aug 3, 2026
Reiterated: Buy
Price Target: $65
Current: $45.91
Upside: +41.58%
Veracyte
Jul 31, 2026
Reiterated: Buy
Price Target: $65
Current: $46.37
Upside: +40.18%
Guardant Health
Jul 31, 2026
Reiterated: Buy
Price Target: $190
Current: $162.10
Upside: +17.22%
Illumina
Jul 30, 2026
Reiterated: Buy
Price Target: $200 → $226
Current: $205.18
Upside: +10.15%
Neogen
Jul 30, 2026
Reiterated: Buy
Price Target: $12
Current: $12.18
Upside: -1.48%
Adaptive Biotechnologies
Jul 29, 2026
Reiterated: Buy
Price Target: $22 → $25
Current: $23.23
Upside: +7.62%
Nautilus Biotechnology
Jul 28, 2026
Reiterated: Buy
Price Target: $4
Current: $0.977
Upside: +309.42%
Danaher
Jul 21, 2026
Reiterated: Buy
Price Target: $235 → $200
Current: $196.68
Upside: +1.69%
Bruker
Jun 29, 2026
Maintained: Buy
Price Target: $50 → $70
Current: $64.03
Upside: +9.33%
Natera
Jun 29, 2026
Maintained: Buy
Price Target: $270 → $290
Current: $267.34
Upside: +8.48%
Jun 29, 2026
Maintained: Buy
Price Target: $60 → $107
Current: $97.50
Upside: +9.74%
Jun 29, 2026
Maintained: Buy
Price Target: $70 → $74
Current: $66.43
Upside: +11.40%
Jun 29, 2026
Maintained: Buy
Price Target: $120 → $125
Current: $137.01
Upside: -8.77%
May 26, 2026
Reiterated: Buy
Price Target: $75
Current: $71.00
Upside: +5.63%
May 11, 2026
Reiterated: Buy
Price Target: $440
Current: $376.74
Upside: +16.79%
May 11, 2026
Maintained: Hold
Price Target: n/a
Current: $6.58
Upside: -
May 7, 2026
Maintained: Buy
Price Target: $13
Current: $13.01
Upside: -0.08%
May 7, 2026
Maintained: Buy
Price Target: $47
Current: $29.53
Upside: +59.19%
May 6, 2026
Reiterated: Buy
Price Target: $7
Current: $5.70
Upside: +22.81%
May 5, 2026
Maintained: Buy
Price Target: $10 → $12
Current: $15.15
Upside: -20.79%
Feb 24, 2026
Maintained: Hold
Price Target: n/a
Current: $144.88
Upside: -
Feb 12, 2026
Maintained: Hold
Price Target: n/a
Current: $1.45
Upside: -
Oct 28, 2025
Maintained: Hold
Price Target: n/a
Current: $15.89
Upside: -
Oct 27, 2025
Reiterated: Hold
Price Target: n/a
Current: $115.27
Upside: -
Oct 16, 2025
Reiterated: Buy
Price Target: €263.00
Current: €228.20
Upside: +15.25%
Jul 13, 2025
Initiated Coverage: Buy
Price Target: $32
Current: $16.48
Upside: n/a
Apr 8, 2025
Downgraded: Hold
Price Target: n/a
Current: $3.04
Upside: n/a
Feb 23, 2025
Maintained: Hold
Price Target: n/a
Current: $47.36
Upside: n/a